Michael J. Fox and Sergey Brin Take Their Push for a Parkinson’s Cure to the Next Level
Bloomberg News provides a deep dive into our work and our partnership with The Michael J. Fox Foundation. Working together, we're proud to be at the forefront of Parkinson’s disease research. Register for free to access the article.
Structures of Parkinson’s disease-linked proteins offer a framework for understanding how they work together
This story discusses Team Alessi’s research at St. Jude Children’s Research Hospital that used cryo-electron microscopy to characterize the interaction of two proteins implicated in Parkinson’s disease.
A substantial number of Parkinson’s disease cases can be attributed to preventable risk factors, new research finds
This news story discusses a research study by Team Liddle in Nature’s Parkinson’s Disease journal that found that preventable risk factors play a significant role in a person’s potential of developing Parkinson’s disease.
Tiny pieces of discarded plastics like styrofoam may promote Parkinson’s
This story reports on a research study by Team Liddle that found that nanoplastics that can reach a person’s brain can increase the risk of Parkinson’s disease or its progression by prompting the protein alpha-synuclein to clump and turn toxic.
2023 ASAP Collaborative Meeting series – A look back
ASAP’s 2023 Collaborative Meetings welcomed core leadership and trainees from each CRN team to create a space to make connections, share their work, and spark new ideas that spanned career levels, disciplines, and continents. Each event showcased participants who received awards for their work that they presented at the meeting.
Risk factor for Parkinson’s discovered in genes from people of African descent
Read NPR's coverage of GP2's historic GBA1 finding. This article by Jon Hamilton includes interviews with ASAP's Managing Director, Dr. Ekemini A. U. Riley, and lead GP2 study researchers, Andy Singleton and Sara Bandres-Ciga.
